Investor Presentation Q1 2023

56 Investor presentation First three months of 2023 Global obesity market growth has been accelerating with Novo Nordisk capturing the majority of growth 180% 140% 100% 60% 20% Obesity market growth and Novo Nordisk value market share Obesity market size and growth DKK billion 180% 140% 94% 12.8 89% 100% 16.7 78% 60% 20% 81% -78% 29.7 0.2 89% -94% Feb 2023 Others -20% -20% Feb 2020 Feb -NN market share 2023 Feb 2022 NN Obesity care Others -Market growth (right axis) Novo Nordisk NN Growth (right axis) Source: IQVIA, Feb 2023 Value MAT, all countries; Share of growth not depicted due to high growth Novo NordiskⓇ

View entire presentation